Results 261 to 270 of about 1,141,456 (326)

A comparative immunohistochemical and histomorphometric analysis of human gingiva in smokers and non-smokers with periodontitis : a cross-sectional study. [PDF]

BMC Oral Health
Reddy SSP, Francis DL, Boruah D, Giri AK.   +3 more
europepmc   +1 more source

The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism

BioMed Research International, Volume 2026, Issue 1, 2026.
Asthma is a heterogeneous disease that affects individuals of diverse age groups globally and exhibits variable responses to different treatments. Type 2 inflammation contributes to the pathogenesis of asthma through the production of cytokines IL‐4, IL‐5, and IL‐13, thereby inducing characteristic features of asthma such as elevated eosinophil levels ...
Lanying Cheng, Lihong Sun, Baisakhi Banerjee   +2 more
wiley   +1 more source

The Glycemia Risk Index (GRI) as a Biomarker for Subclinical Endothelial Dysfunction in Type 1 Diabetes: A Cross-Sectional Study. [PDF]

Int J Mol Sci
Di Martino N, Angelino S, Maio A, Cirillo P, Pontillo A, Caputo M, Scappaticcio L, Caruso P, Longo M, Bellastella G, Maiorino MI, Esposito K.   +11 more
europepmc   +1 more source

Stage IV SMARCA4‐Deficient Undifferentiated Malignant Neoplasm With Primary Cutaneous Origin and Early Distant Metastases

Case Reports in Dermatological Medicine, Volume 2026, Issue 1, 2026.
SMARCA4‐deficient undifferentiated malignant neoplasms (SD‐UMNs) are a recently recognized group of malignant epithelioid tumors, associated with mutations in the SWItch/Sucrose nonfermentable chromatin remodeling complex. To our knowledge, there have been only three cases of SD‐UMNs primary to the skin.
Katlyn M. Smaha, Matthew Willett, David E. Kent, Semonti Nandi   +3 more
wiley   +1 more source

A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias. [PDF]

Leukemia
Pérez-Amill L, Armand-Ugón M, Val-Casals M, Martín-Herreros B, Álamo JR, Peña S, Frigola G, Altuna A, Santos C, Guijarro F, Minguela A, Bataller À, Casanovas-Albertí B, Uribe-Herranz M, Navarro I, Guerreiro M, Sánchez-Martínez D, Tirado N, Velasco-Hernandez T, Menéndez P, Martínez A, Rovira M, Colomer D, González-Navarro EA, Esteve J, Urbano-Ispizua Á, Montesinos P, Delgado J, Juan M, Klein-González N.   +29 more
europepmc   +1 more source

Safety, Feasibility, and Preliminary Efficacy of Allogeneic MSCs to Treat Advanced Femoral Head Osteonecrosis (ALOFEM): A Pilot Study in Young Onco‐Hematological Patients

Stem Cells International, Volume 2026, Issue 1, 2026.
Background Severe osteonecrosis of the femoral head (ONFH) secondary to corticosteroid therapy in symptomatic, hematological young patients currently has no therapeutic alternative, and early total hip replacement (THR) is a high‐risk intervention in those patients.
Enrique Gómez-Barrena, Norma G. Padilla-Eguiluz, Juan Cabello-Blanco, José Juan Pozo-Kreilinger, Yasmina Mozo-del-Castillo, María E. Martínez-Muñoz, Trinidad Martín-Donaire, Rocío Zafra, Rafael F. Duarte, Ana Velasco-Iglesias, Cristina Avendaño-Solà, Concepción Payares-Herrera, Harleen Khatra   +12 more
wiley   +1 more source

Immunophenotypic Profiling of Acute Promyelocytic Leukemia: Insights From a Large Cohort. [PDF]

Cancer Rep (Hoboken)
Kankhaw S, Owattanapanich W, Promsuwicha O, Thong-Ou T, Ruchutrakool T, Khuhapinant A, Paisooksantivatana K, Kungwankiattichai S.   +7 more
europepmc   +1 more source

Primary epithelioid angiosarcoma of the jejunum presenting with severe anemia and distant metastasis: a case report and literature review. [PDF]

Front Oncol
Liu S, Zhang J, Wang X.
europepmc   +1 more source

Lineage Switch of Adult B-Cell Acute Lymphoblastic Leukaemia to Acute Myeloid Leukaemia Following B-Cell-Directed Therapy. [PDF]

Eur J Case Rep Intern Med
Borja-Montes OF, Horton DD, Toro-Pedroza A, Escobar-Gil T, Babu D, Foucar C, Ebaid A.   +6 more
europepmc   +1 more source

Soft-Tissue Sarcomas-A Correlation Among Tumor Margin Infiltration, Immunological Markers, and Survival Rate. [PDF]

Int J Mol Sci
Șerban B, Cursaru A, Iordache S, Costache M, Cretu B, Dumitru A, Cirstoiu C.   +6 more
europepmc   +1 more source